Amylyx Pharmaceuticals, Inc. (AMLX)
NASDAQ: AMLX · IEX Real-Time Price · USD
1.780
-0.100 (-5.32%)
At close: Apr 25, 2024, 4:00 PM
1.790
+0.010 (0.56%)
Pre-market: Apr 26, 2024, 8:46 AM EDT
Amylyx Pharmaceuticals Stock Forecast
AMLX's stock price has decreased by -93.98% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
The 5 analysts with 12-month price forecasts for AMLX stock have an average target of 11, with a low estimate of 3.00 and a high estimate of 32. The average target predicts an increase of 517.98% from the current stock price of 1.78.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for AMLX stock from 7 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Nov '23 | Dec '23 | Jan '24 | Feb '24 | Mar '24 | Apr '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 5 | 6 | 6 | 6 | 4 | 3 |
| Buy | 0 | 0 | 1 | 1 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 4 | 4 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 6 | 7 | 7 | 8 | 7 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Baird | Baird | Hold Maintains $4 → $3 | Hold | Maintains | $4 → $3 | +68.54% | Apr 11, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $8 | Strong Buy | Reiterates | $8 | +349.44% | Apr 11, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $8 | Strong Buy | Maintains | $8 | +349.44% | Apr 8, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $42 → $8 | Strong Buy | Maintains | $42 → $8 | +349.44% | Mar 12, 2024 |
| Deutsche Bank | Deutsche Bank | Strong Buy Maintains $36 → $8 | Strong Buy | Maintains | $36 → $8 | +349.44% | Mar 11, 2024 |
Financial Forecast
Revenue This Year
104.32M
from 380.79M
Decreased by -72.60%
Revenue Next Year
338.62M
from 104.32M
Increased by 224.60%
EPS This Year
-1.61
from 0.70
EPS Next Year
-0.77
from -1.61
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 139.2M | 601.3M | 692.0M | 1.2B | 1.3B |
| Avg | 104.3M | 338.6M | 394.4M | 1.0B | 1.1B |
| Low | 71.1M | n/a | n/a | 832.5M | 911.1M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -63.4% | 476.4% | 104.3% | 197.4% | 25.0% |
| Avg | -72.6% | 224.6% | 16.5% | 158.4% | 7.3% |
| Low | -81.3% | - | - | 111.1% | -10.6% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -0.26 | 0.97 | 2.30 | 5.25 | 4.28 |
| Avg | -1.61 | -0.77 | -0.55 | 4.49 | 4.16 |
| Low | -2.60 | -1.93 | -1.79 | 3.72 | 4.00 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | - | -4.5% |
| Avg | - | - | - | - | -7.3% |
| Low | - | - | - | - | -10.9% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.